Nurix therapeutics announces webcast to review data from its phase 1 clinical trial of btk degrader, nx-2127, presented at the 64th american society of hematology annual meeting

Webcast scheduled for monday, december 12, 2022 at 8:30 pm ct (9:30 pm et) webcast scheduled for monday, december 12, 2022 at 8:30 pm ct (9:30 pm et)

NRIX Ratings Summary

NRIX Quant Ranking